# Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma

> **NCT02732665** · — · COMPLETED · sponsor: **Jens Nielsen** · enrollment: 50 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02732665
- **Lead sponsor:** Jens Nielsen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2020-12
- **Final completion:** 2021-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-04-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02732665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02732665, "Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02732665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*